Literature DB >> 8214232

Race and survival time with AIDS: a synthesis of the literature.

J R Curtis1, D L Patrick.   

Abstract

OBJECTIVE: This study summarizes the evidence concerning the association of Black and White race with acquired immunodeficiency syndrome (AIDS) survival time.
METHODS: English-language articles measuring survival time with AIDS for Black and White persons were reviewed. Each article was assigned to one of three groups based on the method of subject accrual.
RESULTS: Of the nine eligible studies identified, five studies had inclusive methods of accruing study subjects, and four of these five showed decreased survival time among Black persons. In the studies with more restrictive accrual methods, survival time for Blacks was not decreased.
CONCLUSIONS: Although the published studies vary in their results, this variation appears to be systematic according to the method of accruing study subjects. If the accrual method serves to minimize socioeconomic differences between Blacks and Whites, there is no difference in survival time by race. However, if a more inclusive method is used, a significant decrease in AIDS survival time is observed among Blacks. This analysis suggests that, in some studies, race may function as a marker for socioeconomic factors and/or access to health care and that AIDS patients in the lowest socioeconomic or access group have significantly shorter survival times.

Entities:  

Mesh:

Year:  1993        PMID: 8214232      PMCID: PMC1694860          DOI: 10.2105/ajph.83.10.1425

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  20 in total

1.  A new prognostic staging system for the acquired immunodeficiency syndrome.

Authors:  A C Justice; A R Feinstein; C K Wells
Journal:  N Engl J Med       Date:  1989-05-25       Impact factor: 91.245

2.  Racial/ethnic differences in the risk of AIDS in the United States.

Authors:  R M Selik; K G Castro; M Pappaioanou
Journal:  Am J Public Health       Date:  1988-12       Impact factor: 9.308

3.  Representation of American blacks in clinical trials of new drugs.

Authors:  C K Svensson
Journal:  JAMA       Date:  1989-01-13       Impact factor: 56.272

4.  Zidovudine and the natural history of the acquired immunodeficiency syndrome.

Authors:  R D Moore; J Hidalgo; B W Sugland; R E Chaisson
Journal:  N Engl J Med       Date:  1991-05-16       Impact factor: 91.245

5.  Survival experience among patients with AIDS receiving zidovudine. Follow-up of patients in a compassionate plea program.

Authors:  T Creagh-Kirk; P Doi; E Andrews; S Nusinoff-Lehrman; H Tilson; D Hoth; D W Barry
Journal:  JAMA       Date:  1988-11-25       Impact factor: 56.272

6.  Survival trends for patients with AIDS.

Authors:  G F Lemp; S F Payne; D Neal; T Temelso; G W Rutherford
Journal:  JAMA       Date:  1990-01-19       Impact factor: 56.272

7.  The incidence of AIDS among blacks and Hispanics.

Authors:  R Bakeman; E McCray; J R Lumb; R E Jackson; P N Whitley
Journal:  J Natl Med Assoc       Date:  1987-09       Impact factor: 1.798

8.  Survival differences in patients with AIDS.

Authors:  G H Friedland; B Saltzman; J Vileno; K Freeman; L K Schrager; R S Klein
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1991

9.  Survival with the acquired immunodeficiency syndrome. Experience with 5833 cases in New York City.

Authors:  R Rothenberg; M Woelfel; R Stoneburner; J Milberg; R Parker; B Truman
Journal:  N Engl J Med       Date:  1987-11-19       Impact factor: 91.245

10.  Differences in access to zidovudine (AZT) among symptomatic HIV-infected persons.

Authors:  M D Stein; J Piette; V Mor; T J Wachtel; J Fleishman; K H Mayer; C C Carpenter
Journal:  J Gen Intern Med       Date:  1991 Jan-Feb       Impact factor: 5.128

View more
  6 in total

1.  Access to HIV services by the urban poor.

Authors:  I D Montoya; R A Trevino; D L Kreitz
Journal:  J Community Health       Date:  1999-10

2.  Demographic characteristics and survival with AIDS: health disparities in Chicago, 1993-2001.

Authors:  Girma Woldemichael; Demian Christiansen; Sandra Thomas; Nanette Benbow
Journal:  Am J Public Health       Date:  2009-02-12       Impact factor: 9.308

3.  Access of vulnerable groups to antiretroviral therapy among persons in care for HIV disease in the United States. HCSUS Consortium. HIV Cost and Services Utilization Study.

Authors:  R Andersen; S Bozzette; M Shapiro; P St Clair; S Morton; S Crystal; D Goldman; N Wenger; A Gifford; A Leibowitz; S Asch; S Berry; T Nakazono; K Heslin; W Cunningham
Journal:  Health Serv Res       Date:  2000-06       Impact factor: 3.402

4.  Measuring social class differences in cancer patient survival: is it necessary to control for social class differences in general population mortality? A Finnish population-based study.

Authors:  P W Dickman; A Auvinen; E T Voutilainen; T Hakulinen
Journal:  J Epidemiol Community Health       Date:  1998-11       Impact factor: 3.710

5.  Race, place and AIDS: the role of socioeconomic context on racial disparities in treatment and survival in San Francisco.

Authors:  Michael Arnold; Ling Hsu; Sharon Pipkin; Willi McFarland; George W Rutherford
Journal:  Soc Sci Med       Date:  2009-05-13       Impact factor: 4.634

6.  AIDS in Africans living in London.

Authors:  N O'Farrell; R Lau; K Yoganathan; C S Bradbeer; G E Griffin; A L Pozniak
Journal:  Genitourin Med       Date:  1995-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.